After millennia of use and nearly a century of investigation the parameters of efficacy for devices alleged to restore tissue following trauma are quickly evolving. With that arrival we will see drugs and surgery replaced in classes of applications involving inflammation, trauma, illness and aging. EB Wilson noted, “the key to every biological problem must finally be sought in the cell”. A physicist or physical chemist might have said “in the electron”, and thus electrochemistry and electro-genomics as successors to molecular physiology. The juxtaposition of unparalleled safety and increased efficacy over drugs warrants an informed professional and consumer activism to see this technology assume its correct position as central to future healthcare. If “primum non nocere” has meaning, the universal force of electromagnetism is the place to begin.

Glen Gordon MD, A graduate of Creighton University, served in the USN during the Vietnam conflict and followed that with an Assistant Department Head position at NIH. Entering private practice in Sports Medicine, he began investigating soft tissue injuries in humans using nanosecond pulsed field (nPEMF) technology in 1980. Working 20 years with Donald Haueisen PhD, they were awarded the first patent on nanosecond PEMF technology and plan to bring the technology to American families at affordable prices. Bolstered by the recent NASA study that found dB/dt critical to efficacy he speaks widely on the electro-genomic and electrochemical efficacy of this technology.

DVD 49 MINUTES NTSC